remimazolam combined with remifentanil
KY20240514-01
Unknown small_molecule active
Quick answer
remimazolam combined with remifentanil for Difficult or Failed Intubation is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Difficult or Failed Intubation
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active